Literature DB >> 19377253

Elevated serum C-reactive protein level and microalbuminuria in patients with type 2 diabetes mellitus.

Mohammad Javad Mojahedi Mojahedi1, Shokoofeh Bonakdaran, Maryam Hami, Mohammad Reza Sheikhian, Mohammad Taghi Shakeri, Hossein Aiatollahi.   

Abstract

INTRODUCTION: Microalbuminuria is a marker of vascular endothelial damage. In addition, it is reported that high serum levels of C-reactive protein (CRP) is a novel cardiovascular risk factor that impairs endothelial function. The aim of this study was to evaluate the relationship between microalbuminuria and elevated serum level of high-sensitivity CRP (HS-CRP) in type 2 diabetic patients.
MATERIALS AND METHODS: We measured serum levels of HS-CRP in 87 patients with type 2 diabetes mellitus. They were divided into a microalbuminuric group (n = 45) and those with a 24-hour urine albumin less than 30 mg/d (n = 42). The relationship of serum HS-CRP level with albuminuria and other characteristics of the patients was assessed.
RESULTS: Patients with microalbuminuria were significantly older and affected by diabetes mellitus longer than those without microalbuminuria. Also, their mean HS-CRP was significantly higher (4.98 +/- 1.45 mg/L versus 2.82 +/- 2.10 mg/L; P < .001). The Pearson correlation test showed a significant correlation between HS-CRP level and urine albumin level (r = 0.43; P < .001). The specificity and sensitivity of HS-CRP for detection of microalbuminuria in were 78.5% and 68.8%, respectively, and the positive and negative predictive values were 77.5% and 70.2%, respectively.
CONCLUSIONS: In type 2 diabetic patients, microalbuminuria is accompanied by elevated HS-CRP, suggesting activation of inflammatory pathways in progression of renal and cardiovascular atherosclerotic disease. As an easier and cheaper test for assessment of diabetic nephropathy, we recommend further studies on HS-CRP in diabetic patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19377253

Source DB:  PubMed          Journal:  Iran J Kidney Dis        ISSN: 1735-8582            Impact factor:   0.892


  7 in total

1.  Neutrophil-to-lymphocyte ratio and red blood cell distribution width as predictors of microalbuminuria in type 2 diabetes.

Authors:  Tikva Assulyn; Rola Khamisy-Farah; William Nseir; Amir Bashkin; Raymond Farah
Journal:  J Clin Lab Anal       Date:  2020-02-25       Impact factor: 2.352

2.  Improvement of renal oxidative stress markers after ozone administration in diabetic nephropathy in rats.

Authors:  Mohamed D Morsy; Waleed N Hassan; Sherif I Zalat
Journal:  Diabetol Metab Syndr       Date:  2010-05-13       Impact factor: 3.320

3.  Effects of percutaneous lower-extremity arterial interventions on endothelial function and inflammation response in patients with both type 2 diabetes and lower-extremity peripheral arterial disease.

Authors:  Yaping Du; Fujun Wang; Huiqing Qi; Haixia Ding; Lin Hou; Qian Gao; Miao Tan; Yueqin Liu; Na Xing; Jin Sun
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

4.  Predictive modeling using a nationally representative database to identify patients at risk of developing microalbuminuria.

Authors:  Lorenzo Villa-Zapata; Terri Warholak; Marion Slack; Daniel Malone; Anita Murcko; George Runger; Michael Levengood
Journal:  Int Urol Nephrol       Date:  2015-12-11       Impact factor: 2.370

5.  A Study on the Level of Oxidative Stress and Inflammatory Markers in Type 2 Diabetes Mellitus Patients with Different Treatment Modalities.

Authors:  Siva Prasad Palem; Philips Abraham
Journal:  J Clin Diagn Res       Date:  2015-09-01

6.  Effects of fermented red bean extract on nephropathy in streptozocin-induced diabetic rats.

Authors:  Kung-Chi Chan; Kar-Eng Kok; Keh-Feng Huang; Yao-Lin Weng; Yun-Chin Chung
Journal:  Food Nutr Res       Date:  2020-12-22       Impact factor: 3.894

7.  A Comparative Study of High Sensitivity C-Reactive Protein and Metabolic Variables in Type 2 Diabetes Mellitus with and without Nephropathy.

Authors:  Abid K Shaheer; Jithesh K Tharayil; Parvathi W Krishna
Journal:  J Clin Diagn Res       Date:  2017-09-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.